Stryker Receives FDA Clearance for Ultrasonic Tissue Removal Platform

09:36 AM EDT, 10/14/2026 (MT Newswires) -- Stryker (SYK) has received 510(k) clearance for its ultrasonic bone and soft tissue removal platform Sonopet 3 from the US Food and Drug Administration, the company said Wednesday. The first clinical cases using the new platform are expected to begin in October, and a full commercial launch is expected later in the fall, Stryker said. Price: 284.07, Change: +1.47, Percent Change: +0.52